3: 결과 확인

AUClast


        

Cmax


          

Tmax


          

참고 문헌

  • Kyun-Seop Bae (2018). BE: Bioequivalence Study Data Analysis. R package version 0.1.1. https://CRAN.R-project.org/package=BE
  • Sungpil Han (2019) Edison App: Bioequivalence Study Data Analysis https://github.com/asancpt/edison-BE
  • Chow S-C, Liu J-p. (2009) Design and analysis of bioavailability and bioequivalence studies. Chapman & Hall/CRC biostatistics series, vol 27, 3rd edn. CRC Press, Boca Raton
  • Kyungmee Choi et al. (2012) “임상시험에서 사용되는 기본통계개념에 관한 고찰”, J Korean Soc Clin Pharmacol Ther;20(2):109-124 (119쪽 참고) https://synapse.koreamed.org/pdf/10.12793/jkscpt.2012.20.2.109
  • Schutz et al. (2014), “Reference Datasets for 2-Treatment, 2-Sequence, 2-Period Bioequivalence Studies”, AAPS J.; 16(6): 1292–1297. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389751/
  • Sauter R et al., (1992) “Presentation of results from bioequivalence studies.” Int J Clin Pharmacol Ther Toxicol. 30:S7–30.
  • Clayton D, Leslie A. (1981) “The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before or after food.” J Int Med Res. 9:470–7.